Related Experiment Video
Updated: Feb 6, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Technical Feasibility of the RHYTHMIA Mapping System in Pediatric Patients Weighing Less Than 20Kg
Wataru Sasaki1, Taisuke Nabeshima2, Kouta Nagaoka2
1Department of Cardiology, Saitama Medical University International Medical Center, Saitama, Japan.
The RHYTHMIA mapping system is safe and effective for pediatric catheter ablation in patients under 20 kg. This high-density mapping system allows for successful treatment of supraventricular arrhythmias with no increase in complications.
Area of Science:
- Pediatric Electrophysiology
- Cardiac Arrhythmia Management
- Minimally Invasive Cardiac Procedures
Background:
- Pediatric catheter ablation presents unique technical challenges.
- The RHYTHMIA high-density mapping system is gaining traction in pediatric electrophysiology.
- Limited data exists on its use in very low-weight pediatric patients (<20 kg).
Purpose of the Study:
- To evaluate the feasibility and safety of the RHYTHMIA mapping system in pediatric patients weighing less than 20 kg.
- To compare procedural parameters between pediatric patients <20 kg and ≥20 kg undergoing catheter ablation.
- To assess the incidence of complications in these patient groups.
Main Methods:
- Retrospective analysis of 125 pediatric patients undergoing catheter ablation for supraventricular arrhythmias using the RHYTHMIA system.
- Patients divided into two groups: <20 kg (n=14) and ≥20 kg (n=111).
- Comparison of mapping time, beats, electrodes, re-annotations, and complications in the right atrium (RA) and left atrium (LA).
Main Results:
- No significant differences in mapping time, accepted beats, or electrograms were found between the <20 kg and ≥20 kg groups for both RA and LA.
- The <20 kg group required more manual re-annotations in the RA.
- No significant differences in procedural complications were observed between the groups.
Conclusions:
- The RHYTHMIA mapping system is technically feasible for pediatric patients weighing less than 20 kg.
- Its use in this population is not associated with major procedural complications.
- Cautious application with careful patient selection and operator vigilance is recommended.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Microtubule Associated Proteins (MAPs)
Plotting of Topographic Maps

